Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The lose of Brian and Wolf will hurt the value of this message board.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Yes that's my interpretation, otherwise, it seems there would be no NEED for a PR, as the agreements would take care of the disposition of funds, and funding of the working capital back to the prescribed ranges. The PR to me represents a deviation from the original agreements, and the SUBSTANTIAL qualifier implies serious change, IMO.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply